ERp72 Activators

ERp72 Activators encompass a diverse range of compounds that can induce or enhance the functional activity of ERp72, a protein that plays a key role in the endoplasmic reticulum's response to stress and its associated unfolded protein response (UPR). For instance, Thapsigargin raises intracellular calcium levels by inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), which causes ER stress and subsequently increases the activity of ERp72 to counteract the detrimental effects of calcium depletion on protein folding. Tunicamycin, by inhibiting N-linked glycosylation, enforces a similar stress upon the ER, which results in upregulation and enhanced activity of ERp72 as it attempts to address the accumulation of misfolded glycoproteins. Other compounds, such as Brefeldin A, Dithiothreitol (DTT), and 2-Deoxy-D-glucose, exert their effects through different mechanisms but converge on the common outcome of promoting ER stress. Brefeldin A disrupts protein transport between the ER and Golgi apparatus, DTT interferes with disulfide bond formation in the ER, and 2-Deoxy-D-glucose inhibits proper glycosylation-all of which heighten the demand for ERp72's chaperone activity as thecell attempts to restore homeostasis. Proteasome inhibitors like MG132 cause the accumulation of misfolded proteins within the ER, which can overwhelm the protein folding machinery, leading to an increase in ERp72 activity as the protein works to refold or degrade these misfolded proteins. Metal stressors such as Arsenite and Cadmium chloride elicit oxidative stress and disrupt calcium homeostasis, respectively, both of which necessitate greater involvement of ERp72 in the management of protein folding.

The activity of ERp72 is also enhanced by chemicals that affect the protein degradation pathway. For example, Eeyarestatin I inhibits ER-associated degradation (ERAD), leading to an increased load of misfolded proteins within the ER and a subsequent upregulation of ERp72 activity to manage this protein burden. Similarly, Geldanamycin binds to Hsp90, a chaperone that, when inhibited, can cause a buildup of unfolded proteins, indirectly necessitating an increase in ERp72 function. Chloroquine's ability to alter the ER environment by changing its pH levels also contributes to protein misfolding, enhancing the demand for ERp72's protein-folding capabilities. Each of these compounds, through their unique impacts on cellular and molecular functions, ultimately contributes to the enhancement of ERp72's role in maintaining protein homeostasis within the endoplasmic reticulum.